semaglutide chemical structure Oral Semaglutide In The Management
Description
Periprocedural diabetic ketoacidosis (DKA) with SGLT2 inhibitor use in people with diabetes

Research published in the journal Climacteric demonstrates that while weight gain itself cannot be attributed solely to menopause, the hormonal changes substantially alter where fat accumulates

doi: 10.1038/s41467-021-20904-2 143 YeZZhuoQHuQXuXMengqiLZhangZet al

However: There is no strong evidence that GLP-1 therapy directly reduces intestinal absorption efficiency in otherwise healthy individuals
If a blanket policy is only applied to the diabetes patient, a lot of people who potentially benefit from these medications will lose the opportunity
